Multi-line Drug Screen Test A drug-positive urine specimen will not generate a colored line in the specific test line region of the strip INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques because of drug competition, while a drug-negative urine specimen will generate a line in the test line region are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test Device (Urine) because of the absence of drug competition. To serve as a procedural control, a colored line will always device. If the problem persists, discontinue using the lot immediately and contact your local distributor. appear at the control line region, indicating that proper volume of specimen has been added and membrane QUALITY CONTROL wicking has occurred. Package insert for testing of any combination of the following drugs: A procedural control is included in the test. A colored line appearing in the control line region (C) is Amphetamine 300, Amphetamine 500, Amphetamine, Barbiturates, Benzodiazepines 200, Benzodiazepines, REAGENTS considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane Buprenorphine, Cocaine 150, Cocaine, Cotinine, Fentanyl, Ketamine, Marijuana 20, Marijuana, Marijuana Each test in the test device contains specific drug antibody-coupled particles and corresponding drug-protein wicking and correct procedural technique. 150, Methadone, EDDP 100 (Methadone metabolite), EDDP 300 (Methadone metabolite), Methamphetamine conjugates. A goat antibody is employed in each control line. Control standards are not supplied with this kit. However, it is recommended that positive and negative 300, Methamphetamine 500, Methamphetamine, Methylenedioxymethamphetamine, Morphine 300, Opiate controls be tested as good laboratory practice to confirm the test procedure and to verify proper test performance. 2000, Oxycodone, Phencyclidine, Propoxyphene, Tramadol and Tricyclic Antidepressants. PRECAUTIONS LIMITATIONS A rapid, one step screening test for the simultaneous, qualitative detection of multiple drugs and drug • For medical and other professional in vitro diagnostic use only. Do not use after the expiration date. metabolites in human urine. • The test device should remain in the sealed pouch until use. 1. The Multi-Drug One Step Multi-Line Screen Test Device (Urine) provides only a qualitative, preliminary For medical and other professional in vitro diagnostic use only. • All specimens should be considered potentially hazardous and handled in the same manner as an analytical result. A secondary analytical method must be used to obtain a confirmed result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method.2, 3 INTENDED USE & SUMMARY infectious agent. 2. There is a possibility that technical or procedural errors, as well as other interfering substances in the urine • The used test device should be discarded according to local regulations. Urine based tests for multiple drugs of abuse range from simple immunoassay tests to complex analytical specimen may cause erroneous results. procedures. The speed and sensitivity of immunoassays have made them the most widely accepted method to STORAGE AND STABILITY 3. Adulterants, such as bleach and/or alum, in urine specimens may produce erroneous results regardless of the screen urine for multiple drugs of abuse. Store as packaged in the sealed pouch either at room temperature or refrigerated (2-30°C). The test device is analytical method used. If adulteration is suspected, the test should be repeated with another urine specimen. The Multi-Drug One Step Multi-line Screen Test Device (Urine) is a lateral flow chromatographic stable through the expiration date printed on the sealed pouch. The test device must remain in the sealed 4. A positive result does not indicate level or intoxication, administration route or concentration in urine. immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following 5. A negative result may not necessarily indicate drug-free urine. Negative results can be obtained when drug 1 pouch until use. DO NOT FREEZE. Do not use beyond the expiration date. cut-off concentrations in urine: is present but below the cut-off level of the test. Test Calibrator Cut-off (ng/mL) SPECIMEN COLLECTION AND PREPARATION 6. The test does not distinguish between drugs of abuse and certain medications. 7. A positive result might be obtained from certain foods or food supplements. Amphetamine (AMP 300) d-Amphetamine 300 Urine Assay PERFORMANCE CHARACTERISTICS Amphetamine (AMP 500) d-Amphetamine 500 The urine specimen must be collected in a clean and dry container. Urine collected at any time of the day may Amphetamine (AMP) d-Amphetamine 1,000 be used. Urine specimens exhibiting visible precipitates should be centrifuged, filtered, or allowed to settle to Accuracy Barbiturates (BAR) Secobarbital 300 obtain a clear supernatant for testing. A side-by-side comparison was conducted using the Multi-Drug One Step Multi-Line Screen Test Device Benzodiazepines (BZO 200) Oxazepam 200 (Urine) and a commercially available drug rapid test. Testing was performed on approximately 300 Specimen Storage Benzodiazepines (BZO) Oxazepam 300 specimens previously collected from subjects presenting for Drug Screen Testing. Presumptive positive Buprenorphine (BUP) Buprenorphine 10 Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For prolonged storage, specimens results were confirmed by GC/MS. Negative urine specimens were screened initially by Predicate test, 10% Cocaine (COC 150) Benzoylecgonine 150 may be frozen and stored below -20°C. Frozen specimens should be thawed and mixed well before testing. negative specimens were confirmed by GC/MS. The following results were tabulated: % Agreement with Commercial Kit Cocaine (COC) Benzoylecgonine 300 MATERIALS AMP AMP BZO COC THC THC Cotinine (COT) Cotinine 100 Specimen AMP BAR BZO BUP** COC COT FTY KET THC Materials Provided 300 500 200 150 20 150 Fentanyl (FTY) Norfentanyl 20 • Droppers Positive >99% * >99% 98% * 98% 88% >99% >99% >99% * * * >99% * Ketamine (KET) Ketamine 1,000 • Test devices • Package insert Negative >99% * >99% >99% * >99% >99% >99% 99% >99% * * * >99% * Marijuana (THC 20) 11-nor-Δ9-THC-9 COOH 20 Materials Required But Not Provided Total >99% * >99% 99% * 99% 97% >99% 99% >99% * * * >99% * Marijuana (THC) 11-nor-Δ9-THC-9 COOH 50 • Specimen collection container • Timer EDDP EDDP MET MET MOP OPI Marijuana (THC 150) 11-nor-Δ9-THC-9 COOH 150 Specimen MTD MET MDMA OXY PCP PPX TRA TCA 100 300 300 500 300 2000 Methadone (MTD) Methadone 300 DIRECTIONS FOR USE Positive 87% * * * >99% >99% 98% 94% 99% 96% >99% >99% * 92% 2-Ethylidene-1,5-dimethyl-3,3-dipheylpyrrolidine Allow the test device, urine specimen, and/or controls to equilibrate to room temperature (15-30C) Methadone metabolite (EDDP 100) 100 Negative >99% * * * 82% >99% >99% >99% >99% 99% >99% >99% * >99% (EDDP) prior to testing. 2-Ethylidene-1,5-dimethyl-3,3-dipheylpyrrolidine Methadone metabolite (EDDP 300) 300 Total 94% * * * 89% >99% 99% 97% 99% 98% >99% >99% * 98% (EDDP) 1. Bring the pouch to room temperature before opening it. Remove the test device from the sealed pouch and * NOTE: Commercial kit unavailable for comparison testing. Methamphetamine (MET 300) d-Methamphetamine 300 use it as soon as possible. ** NOTE: BUP was compared to the self-reported use of Buprenorphine Methamphetamine (MET 500) d-Methamphetamine 500 2. Place the test device on a clean and level surface. Hold the dropper vertically and transfer 3 full drops of % Agreement with GC/MS Methamphetamine (MET) d-Methamphetamine 1,000 urine (approx. 100 µL total volume) to each specimen well (S) of the test device, and then start the timer. AMP AMP BZO COC THC THC Avoid trapping air bubbles in the specimen well (S). See the illustration below. Specimen AMP BAR BZO BUP* COC COT* FTY* KET THC Methylenedioxymethamphetamine (MDMA) d,l-Methylenedioxymethamphetamine 500 300 500 200 150 20 150 Morphine (MOP 300) Morphine 300 3. Wait for the colored lines(s) to appear. Read results at 5 minutes. Do not interpret results after 10 minutes. Positive 99% 95% 94% 92% 98% 98% 98% 97% 95% >99% 99% >99% 91% 95% 91% Opiate (OPI 2000) Morphine 2,000 Negative 99% >99% 99% 99% 99% 98% 99% >99% >99% >99% 89% 97% 99% 96% 96% Oxycodone (OXY) Oxycodone 100 Total 99% 98% 97% 96% 99% 98% 99% 99% 98% >99% 93% 97% 96% 95% 95% Phencyclidine (PCP) Phencyclidine 25 EDDP EDDP MET MET MOP OPI Specimen MTD MET MDMA OXY PCP PPX TRA* TCA** Propoxyphene (PPX) Propoxyphene 300 100 300 300 500 300 2000 Tramadol (TRA) Tramadol 100 Positive 93% >99% >99% 98% 99% 90% 98% 98% 99% 99% 90% 99% 96% >99% Tricyclic Antidepressants (TCA) Nortriptyline 1,000 Negative >99% >99% 95% >99% >99% >99% 98% 97% 99% 98% 99% >99% 97% 94% This test will detect other related compounds, please refer to the Analytical Specificity table in this package Total 97% >99% 97% 99% 99% 95% 98% 97% 99% 99% 96% 99% 97% 95% insert. * NOTE: BUP, COT, FTY and TRA were based on LC/MS data instead of GC/MS. This assay provides only a preliminary analytical test result. A more specific alternate chemical ** NOTE: TCA was based on HPLC data instead of GC/MS. method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass Analytical Sensitivity spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive INTERPRETATION OF RESULTS A drug-free urine pool was spiked with drugs to the concentrations at  50% cut-off and  25% cut-off. The results are used. (Please refer to the illustration above) results are summarized below. PRINCIPLE NEGATIVE:* A colored line in the control line region (C) and a colored line in the test line region (T) Drug Conc. AMP 300 AMP 500 AMP BAR BZO 200 BZO BUP COC 150 COC COT The Multi-Drug One Step Multi-Line Screen Test Device (Urine) is an immunoassay based on the principle for a specific drug indicate a negative result. This indicates that the drug concentration in the urine (Cut-off range) - + - + - + - + - + - + - + - + - + - + of competitive binding. Drugs which may be present in the urine specimen compete against their respective specimen is below the designated cut-off level for that specific drug. 0% Cut-off 90 0 30 0 30 0 30 0 60 0 30 0 90 0 90 0 30 0 90 0 drug conjugate for binding sites on their specific antibody. *NOTE: The shade of color in the test line region (T) may vary, but it should be considered negative -50% Cut-off 90 0 30 0 30 0 30 0 60 0 30 0 90 0 90 0 30 0 90 0 During testing, a urine specimen migrates upward by capillary action. A drug, if present in the urine specimen whenever there is even a faint colored line. -25% Cut-off 73 17 25 5 26 4 23 7 60 0 24 6 79 11 73 17 25 5 90 0 below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will POSITIVE: A colored line in the control line region (C) but no line in the test line region (T) for a Cut-off 43 47 11 19 23 7 14 16 22 38 15 15 49 41 46 44 20 10 49 41 then react with the drug-protein conjugate and a visible colored line will show up in the test line region of the specific drug indicates a positive result. This indicates that the drug concentration in the urine specimen +25% Cut-off 16 74 5 25 7 23 7 23 2 58 6 24 10 80 17 73 5 25 4 86 specific drug strip. The presence of drug above the cut-off concentration will saturate all the binding sites of +50% Cut-off 0 90 0 30 0 30 0 30 0 60 0 30 0 90 0 90 0 30 0 90 the antibody. Therefore, the colored line will not form in the test line region. exceeds the designated cut-off for that specific drug.

DOAIS03-E 15/03/2019 SPINREACT,S.A./S.A.U. Ctra.Santa Coloma, 7 E-17176 SANT ESTEVE DE BAS (GI) SPAIN for MONLAB SL Selva de Mar 48 08019 Barcelona (Spain ) Tel +34 93 433 58 60 Fax +34 93 436 38 94 [email protected]

Diazepam 97 p-Hydroxymethamphetamine 30,000 11-nor-8-THC-9 COOH 20 Nordoxepin 1,000 Drug Conc. FTY KET THC 20 THC THC 150 MTD EDDP 100 EDDP 300 MET 300 Estazolam 125 Mephentermine 50,000 8-THC 10,000 Promazine 1,500 (Cut-off range) - + - + - + - + - + - + - + - + - + Flunitrazepam 25,000 l-Methamphetamine 8,000 9-THC 12,500 Promethazine 25,000 0% Cut-off 90 0 90 0 30 0 30 0 90 0 30 0 90 0 90 0 30 0 α-Hydroxyalprazolam 30 d,l-3,4-Methylenedioxymethamphetamine (MDMA) 2,000 Trimipramine 3,000 -50% Cut-off 90 0 90 0 30 0 30 0 90 0 30 0 90 0 90 0 30 0 d-Lorazepam 3,125 METHYLENEDIOXYMETHAMPHETAMINE (MDMA) -25% Cut-off 79 11 48 42 29 1 24 6 90 0 26 4 80 10 79 11 27 3 Cross-Reactivity Midazolam 195 d,l-3,4-Methylenedioxymethamphetamine (MDMA) 500 Cut-off 36 54 6 84 19 11 15 15 45 45 18 12 51 39 51 39 15 15 A study was conducted to determine the cross-reactivity of the test with compounds in either drug-free urine Nitrazepam 780 d,l-3,4-Methylenedioxyamphetamine (MDA) 3,000 +25% Cut-off 7 83 0 90 6 24 6 24 10 80 5 25 3 87 13 77 5 25 or Amphetamine 300, Amphetamine 500, Amphetamine, Barbiturates, Benzodiazepines 200, Norchlordiazepoxide 780 3,4-Methylenedioxyethylamphetamine (MDEA) 300 Benzodiazepines, Buprenorphine, Cocaine 150, Cocaine, Cotinine, Fentanyl, Ketamine, Marijuana 20, +50% Cut-off 0 90 0 90 0 30 0 30 0 90 0 30 0 90 0 90 0 30 Nordiazepam 780 MORPHINE 300 Marijuana, Marijuana 150, Methadone, EDDP 100, EDDP 300, Methamphetamine 300, Methamphetamine Drug Conc. MET 500 MET MDMAMOP OPI 2000 OXY PCP PPX TRA TCA Temazepam 33 Morphine 300 500, Methamphetamin, Methylenedioxymethamphetamine, Morphine 300, Opiate 2000, Oxycodone, Phencyclidine, Propoxyphene, Tramadol and Tricyclic Antidepressants positive urine. The following (Cut-off range) - + - + - + - + - + - + - + - + - + - + Triazolam 150 Codeine 300 compounds show no cross-reactivity when tested with the Multi-Drug One Step Multi-Line Screen Test 0% Cut-off 90 0 30 0 30 0 30 0 30 0 90 0 30 0 90 0 90 0 30 0 BENZODIAZEPINES Ethylmorphine 6,250 Device (Urine) at a concentration of 100 g/mL. -50% Cut-off 90 0 30 0 30 0 30 0 30 0 90 0 30 0 90 0 90 0 30 0 Oxazepam 300 Hydrocodone 50,000 Non Cross-Reacting Compounds -25% Cut-off 74 16 25 5 27 3 20 10 26 4 78 12 26 4 74 16 90 0 25 5 Alprazolam 196 Hydromorphone 3,125 4-Acetamidophenol Dicyclomine Lidocaine Phenothiazine Bromazepam 1,562 Levorphanol 1,500 Cut-off 45 45 23 7 17 13 18 12 11 19 44 46 19 11 46 44 58 32 13 17 Acetone Diflunisal Lindane Prednisolone +25% Cut-off 15 75 6 24 6 24 7 23 5 25 16 74 5 25 16 74 22 68 7 23 Chlordiazepoxide 1,562 6-Monoacetylmorphine (6-MAM) 400 Acetophenetidin Digoxin Lithium Prednisone +50% Cut-off 0 90 0 30 0 30 0 30 0 30 0 90 0 30 0 90 2 88 0 30 Clobazam 98 Morphine 3--D-glucuronide 1,000 Acetylsalicylic acid 4-Dimethylaminoantipyrine Loperamide d,l-Propanolol Clonazepam 781 Norcodeine 6,250 Albumin Diphenhydramine l-Thyroxine Quinacrine Analytical Specificity Clorazepate 195 Normorphine 100,000 alpha-Naphthaleneacetic Acid 5,5-Diphenylhydantoin Meperidine Quinidine Aminopyrine EMDP Meprobamate Quinine The following table lists the concentration of compounds (ng/mL) that are detected positive in urine by the Delorazepam 1,562 Oxycodone 30,000 Multi-Drug One Step Multi-Line Screen Test Device (Urine) at 5 minutes. Amoxapine Erythromycin Methaqualone R(-) Deprenyl Desalkylflurazepam 390 Oxymorphone 100,000 l-Methamphetamine Amoxicillin β-Estradiol Riboflavin AMPHETAMINE 300 MARIJUANA Diazepam 195 Procaine 15,000 [(-) Deoxyephedrine] 9 d-Amphetamine 300 11-nor- -THC-9 COOH 50 Estazolam 2,500 Thebaine 6,250 Ampicillin Estrone-3-sulfate Methoxyphenamine Salicylic acid Apomorphine Ethyl alcohol Methylphenidate Serotonin d,l-Amphetamine 390 Cannabinol 20,000 Flunitrazepam 390 OPIATE 2000 l-Amphetamine 50,000 11-nor-8-THC-9 COOH 30 Ascorbic acid Ethyl-p-aminobenzoate Methyprylon Seroquel α-Hydroxyalprazolam 1,262 Morphine 2,000 Aspartame Etodolac Metoprolol Sertraline p-Hydroxyamphetamine 1,560 8-THC 15,000 d,l-Lorazepam 1,562 Codeine 2,000 Atropine Famprofazone N-Acetylprocainamide Sodium Chloride 9 p-Hydroxynorephedrine 100,000  -THC 15,000 RS-Lorazepam glucuronide 156 Ethylmorphine 5,000 Benzilic acid Fenoprofen Nalidixic acid Sulfamethazine 3,4-Methylenedioxyamphetamine (MDA) 1,560 MARIJUANA 150 Midazolam 12,500 Hydrocodone 12,500 Benzoic acid Fluoxetine Nalorphine Sulindac Benzydamine Furosemide Naproxen Tetracycline β-Phenylethylamine 100,000 11-nor-9-THC-9 COOH 150 Nitrazepam 98 Hydromorphone 5,000 Brompheniramine Gentisic acid Niacinamide Tetrahydrocortison-3-acetate Phenylpropanolamine (d,l-Norephedrine) 100,000 Cannabinol 25,000 Norchlordiazepoxide 195 Levorphanol 75,000 Caffeine d-Glucose Nifedipine Tetrahydrozoline 8 Tyramine 100,000 11-nor- -THC-9 COOH 500 Nordiazepam 390 6-Monoacetylmorphine (6-MAM) 5,000 Cannabidiol Guaiacol Glyceryl Ether Nimesulide Theophylline AMPHETAMINE 500 8-THC 25,000 Temazepam 98 Morphine 3--D-glucuronide 2,000 Chloral Hydrate Hemoglobin Norethindrone Thiamine d-Amphetamine 500 9-THC 25,000 Triazolam 2,500 Norcodeine 12,500 Chloramphenicol Hydralazine Noscapine Thioridazine Chloroquine Hydrochlorothiazide d,l-Octopamine Tolbutamide d,l-Amphetamine 1,500 EDDP 100 BUPRENORPHINE Normorphine 50,000 Chlorothiazide Hydrocortisone Orphenadrine Trans-2-phenylcyclopropylamine 3,4-Methylenedioxyamphetamine (MDA) 800 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) 100 Buprenorphine 10 Oxycodone 25,000 Chlorpromazine o-Hydroxyhippuric acid Oxalic acid Trazodone Phentermine 1,500 EDDP 300 Buprenorphine 3-D-glucuronide 15 Oxymorphone 25,000 Chlorprothixene 3-Hydroxytyramine Oxolinic acid Triamterene β-Phenylethylamine 50,000 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) 300 Norbuprenorphine 20 Procaine 150,000 Cholesterol Hydroxyzine Oxymetazoline Trifluoperazine Cimetidine Ibuprofen Papaverine Trimethoprim Tryptamine 50,000 METHADONE Norbuprenorphine 3-D-glucuronide 200 Thebaine 100,000 Clonidine Iproniazid Pemoline d,l-Tryptophan COCAINE 150 OXYCODONE Tyramine 25,000 Methadone 300 Cortisone Isoproterenol Penicillin d,l-Tyrosine AMPHETAMINE Doxylamine 50,000 Benzoylecgonine 150 Oxycodone 100 Creatinine Isoxsuprine Pentazocine Uric acid d-Amphetamine 1,000 METHAMPHETAMINE 300 Cocaine 400 Hydrocodone 6,250 Deoxycorticosterone Kanamycin Phenelzine Verapamil d,l-Amphetamine 3,000 d-Methamphetamine 300 Cocaethylene 6,250 Hydromorphone 50,000 Dextromethorphan Ketoprofen Pheniramine Zomepirac l-Amphetamine 50,000 d,l-Amphetamine 100,000 Ecgonine 12,500 Levorphanol 50,000 Diclofenac Labetalol d,l-3,4-Methylenedioxyamphetamine (MDA) 2,000 Chloroquine 25,000 Ecgonine methylester 50,000 Naloxone 37,500 BIBLIOGRAPHY Phentermine 3,000 Ephedrine 100,000 COCAINE Naltrexone 37,500 1. Tietz NW. Textbook of Clinical Chemistry. W.B. Saunders Company. 1986; 1735 BARBITURATES (1R,2S)-l-Ephedrine 100,000 Benzoylecgonine 300 Oxymorphone 200 2. Baselt RC. Disposition of Toxic Multi-Drugs and Chemicals in Man. 2nd Ed. Biomedical Publ., Davis, Secobarbital 300 l-Epinephrine 50,000 Cocaine 780 PHENCYCLIDINE CA. 1982; 488 3. Hawks RL, CN Chiang. Urine Testing for Drugs of Abuse. National Institute for Drug Abuse (NIDA), Cocaethylene 12,500 Phencyclidine 25 Alphenal 150 Fenfluramine 12,500 Research Monograph 73, 1986 Amobarbital 300 p-Hydroxymethamphetamine 25,000 Ecgonine 32,000 4-Hydroxyphencyclidine 12,500 Aprobarbital 200 Mephentermine 50,000 COTININE PROPOXYPHENE PACKAGING Butabarbital 75 l-Methamphetamine 3,125 l-Cotinine 100 d-Propoxyphene 300 Reference Product Cont. Butalbital 2,500 3,4-Methylenedioxymethamphetamine (MDMA) 780 S-l-Nicotine 12,500 d-Norpropoxyphene 300 Butethal 100 Trimethobenzamide 25,000 FENTANYL TRAMADOL DOA214 Device for analysis of 12 Drugs Cyclopentobarbital 600 METHAMPHETAMINE 500 Norfentanyl 20 n-Desmethyl-cis-tramadol 195 (AMP/COC/THC/MET/OPI/PCP/BZO/TCA/BAR/MDMA/MTD/MOP) 25 Pentobarbital 300 d-Methamphetamine 500 Alfentanyl 562,500 o-Desmethyl-cis-tramadol 6,250 DOA215 Device for analysis of 10 Drugs Tests/Kit Phenobarbital 100 d,l-Amphetamine 75,000 Buspirone 12,500 Cis-tramadol 100 (AMP/COC/THC/BZO/TCA/BAR/MET/MOP/MTD/MDMA) BENZODIAZEPINES 200 d-Amphetamine 50,000 Fenfluramine 37,500 Phencyclidine 100,000 DOA216 Device for analysis of 5 Drugs (AMP/COC/THC/MET/MOP) Oxazepam 200 Chloroquine 12,500 Fentanyl 100 Procyclidine 100,000 Alprazolam 30 (1R,2S)-l-Ephedrine 50,000 Sufentanyl 57,500 d,l-O-Desmethyl venlafaxine 25,000 Manufacturer Distributor: 7-Aminoclonazepam 4,000 p-Hydroxymethamphetamine 15,000 KETAMINE TRICYCLIC ANTIDEPRESSANTS SPINREACT, S.A./S.A.U. MONLAB, SL 7-Aminoflunitrazepam 390 Mephentermine 25,000 Ketamine 1,000 Nortriptyline 1,000 Ctra.Santa Coloma, 7 Selva de Mar 48 08019 Barcelona-Spain 7-Aminonitrazepam 625 l-Methamphetamine 4,000 Pentobarbital 50,000 Amitriptyline 1,500 17176 Sant Esteve de Bas-Spain Bromazepam 390 3,4-Methylenedioxymethamphetamine (MDMA) 1,000 Secobarbital 100,000 Clomipramine 12,500 Chlordiazepoxide 300 l-Phenylephrine 100,000 Norketamine 50,000 Desipramine 200 Clobazam 48 β-Phenylethylamine 75,000 MARIJUANA 20 Doxepin 2,000 Clorazepate 97 METHAMPHETAMINE 11-nor-9-THC-9 COOH 20 Imipramine 400 Desalkylflurazepam 1,560 d-Methamphetamine 1,000 Cannabinol 12,500 Maprotiline 2,000

DOAIS03-E 15/03/2019 SPINREACT,S.A./S.A.U. Ctra.Santa Coloma, 7 E-17176 SANT ESTEVE DE BAS (GI) SPAIN for MONLAB SL Selva de Mar 48 08019 Barcelona (Spain ) Tel +34 93 433 58 60 Fax +34 93 436 38 94 [email protected]